The dormant stage of vivax diagnosis coupled with a quantitative assay for G6PD testing or polymorph confirmation is necessary to explore the distribution of classes of G6PD deficiency in the population followed by Primaquine treatment. This evidence concerns the gene G6PD and hyperinsulinemic hypoglycemia, familial, 4.